Rothman Orthopaedics loses $120M in revenue during pandemic; end-of-year revenue expected to be down 20%-30%

Alan Condon -   Print  |

Rothman Orthopaedic Institute has lost $120 million in revenue during the COVID-19 pandemic and is anticipating revenue to be down between 20 percent and 30 percent by end of year, Burlington County Times reports.

The Philadelphia-based practice racked up more than 4,000 backlogged cases with the elective surgery shutdown earlier in the year, which it has been addressing during the ramp-up period.

Since reopening in the spring, Rothman Orthopaedics has increased its surgical volume to 92 percent and new patient volume to 88 percent of normal volume.

Currently, revenue is down 40 percent, Alexander Vaccaro, MD, PhD, the institute's president, told BCT.

Dr. Vaccaro is forgoing his salary due to several cost-cutting measures the practice has implemented, which also include temporarily shutting down 12 offices and furloughing more than 700 employees. 

Although "things are looking better," Dr. Vaccaro told BCT that the group may cut more costs around services and personnel if the pandemic continues, including closing some of its offices.

More articles on practice management:
Spine robots at 4 device companies: How the tech is developing at Medtronic, Globus Medical & more
Dr. Andrew Dossett to chair Pro Football Hall of Fame's new medical advisory board
5 orthopedic M&As involving 25+ physicians

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers